AlphaGrep UK’s Concentrix CNXC Stock Holding History

AlphaGrep UK’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-22,051	Closed	-$603K	–	771
2026 Q1	$603K	Buy	+22,051	New	+$783K	0.17%	158

Other funds holding CNXC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

KGI

Kopernik Global Investors Tampa, Florida $1.63B AUM 27.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

GBL

Groupe Bruxelles Lambert Brussels, Belgium $62.2M AUM 57.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

AlphaGrep UK's CNXC Position: Q2 2026 in Review

AlphaGrep UK sold out of Concentrix (CNXC) in Q2 2026, closing a stake of 22,051 shares — an estimated $603K sold.

AlphaGrep UK first reported a position in CNXC in Q1 2026 and held it in 1 quarter. The position peaked at $603K in Q1 2026. 249 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

AlphaGrep UK reported no remaining Concentrix position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 22,051 Concentrix shares in Q2 2026, an estimated $603K.
AlphaGrep UK first reported a position in Concentrix in Q1 2026 and held it in 1 quarter.
AlphaGrep UK's Concentrix position peaked at $603K in Q1 2026.
249 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.